The R&D-based biopharmaceutical industry at the forefront of addressing AMR Published on: 15 September 2016 Downloads » Flyer Resources Publications Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance Statements ABPI, EFPIA, and IFPMA issue joint statement on AMR News Releases IFPMA supports WHO world health day: new efforts needed to combat AMR News Releases New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D Related Links Tackling Global Health Challenges-Antimicrobial Resistance The Role of Partnerships in Supporting Innovation to Combat Antimicrobial Resistance (AMR) Related Topics Antimicrobial resistance Tags AMRAntibioticsDiagnosticsdrug resistanceIndustry declarationPublic HealthR&DVaccines
